Recently, some studies have provided several approaches for the induction of antigen-specific CD8+Tregs with suppressive functions [13, 19], but there is currently no reliable protocol for the ex vivo induction and large-scale expansion of human polyclonal CD8+CD103+Foxp3+Tregs to investigate their suppression ability in immune disorders. The gene discussed is ITGAE; the disease is immune system disorder.